Differenzielle Regulation und prognostische Bedeutung von ...

84
7 Literaturverzeichnis
Lasota J, Stachura J, Miettinen M (2006): GISTs with PDGFRA exon 14 mutations represent
subset of clinically favorable gastric tumors with epithelioid morphology. Lab Invest
86, 94-100.
Lasota J, Corless CL, Heinrich MC, Debiec-Rychter M, Sciot R, Wardelmann E, Merkelbach-
Bruse S, Schildhaus HU, Steigen SE, Stachura J et al. (2008): Clinicopathologic
profile of gastrointestinal stromal tumors (GISTs) with primary KIT exon 13 or exon
17 mutations: a multicenter study on 54 cases. Mod Pathol 21, 476-484.
Lavoie JN, L'Allemain G, Brunet A, Müller R, Pouysségur J (1996): Cyclin D1 expression is
regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK
pathway. J Biol Chem 271, 20608-20616.
Lundberg AS, Weinberg RA (1998): Functional inactivation of the retinoblastoma protein
requires sequential modification by at least two distinct cyclin-cdk complexes. Mol
Cell Biol 18, 753-761.
Lundberg AS, Weinberg RA (1999): Control of the cell cycle and apoptosis. Eur J Cancer 35,
531-539.
Lux ML, Rubin BP, Biase TL, Chen CJ, Maclure T, Demetri G, Xiao S, Singer S, Fletcher
CDM, Fletcher JA (2000): KIT extracellular and kinase domain mutations in
gastrointestinal stromal tumors. Am J Pathol 156, 791-795.
Matsumura I, Kitamura T, Wakao H, Tanaka H, Hashimoto K, Albanese C, Downward J,
Pestell RG, Kanakura Y (1999): Transcriptional regulation of the cyclin D1 promoter
by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells.
EMBO J 18, 1367-1377.
Mazur MT, Clark HB (1983): Gastric stromal tumors. Reappraisal of histogenesis. Am J Surg
Pathol 7, 507-519.
Miettinen M, Lasota J (2001): Gastrointestinal stromal tumors--definition, clinical,
histological, immunohistochemical, and molecular genetic features and differential
diagnosis. Virchows Arch 438, 1-12.
Miettinen M, Lasota J (2003): Gastrointestinal stromal tumors (GISTs): definition,
occurrence, pathology, differential diagnosis and molecular genetics. Pol J Pathol 54,
3-24.
Miettinen M, Lasota J (2006): Gastrointestinal stromal tumors: review on morphology,
molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med 130,
1466-1478.
Miettinen M, Virolainen M, Sarlomo-Rikala M (1995): Gastrointestinal stromal tumors-value
of CD34 antigen in their identification and separation from true leiomyomas and
schwannomas. Am J Surg Pathol 19, 207-216.
Miettinen M, Sobin LH, Sarlomo-Rikala M (2000a): Immunohistochemical spectrum of
GISTs at different sites and their differential diagnosis with a reference to CD117
(KIT). Mod Pathol 13, 1134-1142.
Miettinen M, Sarlomo-Rikala M, Sobin LH, Lasota J (2000b): Gastrointestinal stromal tumors
and leiomyosarcomas in the colon: a clinicopathologic, immunohistochemical, and
molecular genetic study of 44 cases. Am J Surg Pathol 24, 1339-1352.
Miettinen M, El-Rifai W, Sobin LH, Lasota J (2002): Evaluation of malignancy and prognosis
of gastrointestinal stromal tumors: a review. Hum Pathol 33, 478-483.
Miettinen M, Sobin LH, Lasota J (2005): Gastrointestinal stromal tumors of the stomach: a
clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases
with long-term follow-up. Am J Surg Pathol 29, 52-68.